Kyber's highly unique, nationally-representative health care claims & EMR data product enables timely and accurate analyses across health care subsectors including for drug, medical device, diagnostics and facilities companies. Transaction-level data allow buyers to develop a large number of KPIs and drive granular insights into the dynamics of product revenue & disease dynamics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/04/20 | $10,000,000 | Series A |
Cowen Investments Sandia Holdings | undisclosed |
